Cargando…
Two Laser Treatments Can Improve Tumor Ablation Efficiency of Chemophototherapy
Chemophototherapy is an emerging tumor ablation modality that can improve local delivery of chemotherapeutic agents. Long circulating doxorubicin (Dox) in porphyrin-phospholipid (PoP) liposomes (LC-Dox-PoP) has previously been developed as an effective chemophototherapy agent. In the present study,...
Autores principales: | Ghosh, Sanjana, Lovell, Jonathan F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704214/ https://www.ncbi.nlm.nih.gov/pubmed/34959464 http://dx.doi.org/10.3390/pharmaceutics13122183 |
Ejemplares similares
-
Folate-Targeted Nanoliposomal Chemophototherapy
por: Chitgupi, Upendra, et al.
Publicado: (2023) -
Immune checkpoint blockade enhances chemophototherapy in a syngeneic pancreatic tumor model
por: Ghosh, Sanjana, et al.
Publicado: (2022) -
Chemophototherapy: An Emerging Treatment Option for Solid Tumors
por: Luo, Dandan, et al.
Publicado: (2016) -
Sphingomyelin Liposomes Containing Porphyrin-phospholipid for Irinotecan Chemophototherapy
por: Carter, Kevin A, et al.
Publicado: (2016) -
Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy
por: Liu, Xue‐Liang, et al.
Publicado: (2021)